STOCK TITAN

Vanguard Capital Management increases stake in Elevance Health (NYSE: ELV) — 16.6M shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Elevance Health Inc ownership disclosure: Vanguard Capital Management reports beneficial ownership of 16,601,224 shares of Common Stock, representing 7.13% of the class as of 03/31/2026. The filer reports sole dispositive power over 16,601,224 shares and sole voting power for 2,255,765 shares. The filing is signed on 04/29/2026.

Positive

  • None.

Negative

  • None.

Insights

Large passive stake by Vanguard Capital Management reported at 7.13%.

Vanguard Capital Management reports 16,601,224 shares beneficially owned, a meaningful institutional holding that exceeds the 5% reporting threshold. The position is primarily exercisable via dispositive power across Vanguard-managed funds and accounts.

Changes in this stake would be visible in subsequent Schedule 13 filings; timing and portfolio decisions rest with the reporting entities and affiliates.

Disclosure clarifies voting and dispositive powers across Vanguard entities.

The filing specifies sole voting power for 2,255,765 shares and sole dispositive power for 16,601,224 shares, noting affiliated Vanguard divisions exercise authority. This delineation is standard for asset-manager filings under SEC guidance.

Governance impact depends on whether Vanguard aggregates votes across funds; any coordinated voting would be shown in future disclosures.

Beneficial ownership 16,601,224 shares as of 03/31/2026
Percent of class 7.13% beneficial ownership percentage
Sole voting power 2,255,765 shares shares with sole power to vote
Sole dispositive power 16,601,224 shares shares with sole power to dispose
Filing type Schedule 13G passive/beneficial ownership report
Beneficially owned regulatory
"reflects the securities beneficially owned, or deemed to be beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole dispositive power regulatory
"Sole power to dispose or to direct the disposition of: 16601224"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Schedule 13G regulatory
"Item 1. (a) Name of issuer: Elevance Health Inc"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





036752103

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Capital Management LLC and the following affiliates of Vanguard Capital Management LLC or business divisions of such affiliates: Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC and Vanguard Investments Australia Ltd. This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Capital Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power. This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Capital Management LLC, or business divisions of such subsidiaries, whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release.


SCHEDULE 13G



Vanguard Capital Management
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:04/29/2026

FAQ

What stake does Vanguard Capital Management report in ELV?

Vanguard Capital Management reports 16,601,224 shares, representing 7.13% of common stock as of 03/31/2026. This figure reflects beneficial ownership across Vanguard-managed funds and related business divisions noted in the filing.

How much voting power does Vanguard report for ELV?

The filing reports sole voting power over 2,255,765 shares. It also reports no shared voting power, with dispositive authority reported separately for the larger beneficial holding.

Does Vanguard control the sale proceeds or dividends for these ELV shares?

Yes. The filing states Vanguard entities have the right to receive or direct receipt of dividends or sale proceeds for the reported 16,601,224 shares, including shares held by Vanguard funds and managed accounts.

What date does the Schedule 13G cover for ELV ownership?

The beneficial ownership amount is reported as of 03/31/2026, and the filing is signed on 04/29/2026. Those dates define the reporting period and signature verification.

Is the 7.13% stake considered an activist position?

The Schedule 13G reports passive beneficial ownership and describes managerial relationships among Vanguard entities. It does not indicate activist intent or plans to influence management in the filing text.